Rebamipide CAS 90098-04-7
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
90098-04-7
Name
Rebamipide
Synonyms
(±)-a-(p-Chlorobenzamido)-1,2-dihydro-2-oxo-4-quinolinepropionic acid
2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid
4-Quinolinepropanoic acid, α-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo- [ACD/Index Name]
4-quinolinepropanoic acid, α-[(4-chlorobenzoyl)amino]-2-hydroxy-
90098-04-7 [RN]
a-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid
Mucosta [Trade name]
N-(4-Chlorbenzoyl)-3-(2-oxo-1,2-dihydro-4-chinolinyl)alanin [German] [ACD/IUPAC Name]
N-(4-Chlorobenzoyl)-3-(2-hydroxyquinolin-4-yl)alanine
N-(4-Chlorobenzoyl)-3-(2-oxo-1,2-dihydro-4-quinoléinyl)alanine [French] [ACD/IUPAC Name]
N-(4-Chlorobenzoyl)-3-(2-oxo-1,2-dihydro-4-quinolinyl)alanine [ACD/IUPAC Name]
N-(4-Chlorobenzoyl)-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine
Proamipide
Rebamipida [Spanish] [INN]
Rebamipide [INN] [JAN] [Wiki]
rébamipide [French] [INN]
Rebamipidum [Latin] [INN]
UNII:LR583V32ZR
ребамипид [Russian] [INN]
ريباميبيد [Arabic] [INN]
瑞巴派特 [Chinese] [INN]
(±)-2-(4-CHLOROBENZOYLAMINO)-3-(2(1H)-QUINOLINON-4-YL)-PROPIONIC ACID
?-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid
[90098-04-7]
139344-42-6 [RN]
2-(4-Chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid
2-(4-chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)Propanoic acid
2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid
2-(4-chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid
2-(4-Chloro-benzoylamino)-3-(2-oxo-1,2-dihydro-quinolin-4-yl)-propionic acid
2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
2-[(4-chlorophenyl)carbonylamino]-3-(2-oxidanylidene-1H-quinolin-4-yl)propanoic acid
2-[(4-chlorophenyl)carbonylamino]-3-(2-oxo(4-hydroquinolyl))propanoic acid
2-[(4-chlorophenyl)formamido]-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
4-Quinolinepropanoicacid, a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-
4-Quinolinepropanoicacid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-
C052785
MFCD00866895
MFCD11114396
Mucosta;OPC12759;Proamipide;Rebagen
N-[(4-chlorophenyl)carbonyl]-3-(2-hydroxyquinolin-4-yl)alanine
N-[(4-chlorophenyl)carbonyl]-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine
OPC 12759 hydrate
OPC12759
Pharmakon1600-01505310
Pramipide
Rebagen
Rebapimide
VC2518500
α-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid
Molecular Structure
SMILES
c1ccc2c(c1)c(cc(=O)[nH]2)CC(C(=O)O)NC(=O)c3ccc(cc3)Cl
StdInChI
InChI=1S/C19H15ClN2O4/c20-13-7-5-11(6-8-13)18(24)22-16(19(25)26)9-12-10-17(23)21-15-4-2-1-3-14(12)15/h1-8,10,16H,9H2,(H,21,23)(H,22,24)(H,25,26)
StdInChIKey
ALLWOAVDORUJLA-UHFFFAOYSA-N
Molecular Formula
C19H15ClN2O4
Molecular Weight
370.07
MDL Number
MFCD11114396
Properties
Appearance
White crystalline powder
Safety Data
Symbol
GHS06Signal Word
Danger
Hazard Statements
Precautionary Statements
Personal Protective Equipment
Eyeshields, Faceshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
RIDADR
UN 2811 6.1 / PGIII
WGK Germany
3
RTECS
VC2518500
Specifications and Other Information of Our Rebamipide CAS 90098-04-7
Standard
Enterprise standard
Identification Methods
HPLC,HNMR
Assay
99%min
Chlorine content
0.04%max
Heavy Metals
10ppm max
Related substances
0.5%max
Loss on Drying
2%max
Ignition residue
0.1%max
Methanol
0.3%max
Ethanol
0.5%max
Dichloromethane
0.06%max
Acetic acid
0.5%max
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light.
Application
Commonly used in new anti-ulcer drugs.
Rebamipide is a gastric mucosal protective agent, can increase gastric mucosal blood flow, prostaglandin E2 synthesis and gastric mucus secretion, promote epidermal growth factor and its receptor expression, prevention of ulcer occurrence and promote ulcer healing. Studies have shown that it is effective for a variety of experimental gastric ulcer, can promote gastric mucosal prostaglandin production, protect the gastric mucosa from various ulcer-causing factors, suitable for the treatment of gastric ulcer, acute gastritis, acute exacerbation of chronic gastritis, stomach Mucosal lesions, a higher clinical value.
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/rebamipide-cas-90098-04-7/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/rebamipide-cas-90098-04-7/